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# PEFR- Peak expiratory flow rate 
 
# MDI- Metered dose inhaler 
 
# CHC- Community Health Centre 
 
# CXR- chest x-ray 
 
# ECG- electrocardiogram 
 
# B2 agonist - Beta 2 agonist 
 
# DALYs - disability-adjusted life years 
 
# DOH- Department of Health 
 
# QIC- Quality improvement cycle 
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Asthma affects over 300 million people worldwide and is the sixth highest cause of morbidity 
and mortality in South Africa. Mitchell’s Plain is a large suburb in Cape Town, with a 
population of approximately 320 000 people. A previous study in 2006 indicated that 15.7% 
of patients that presented to Mitchell’s Plain Community Health Care casualty were for an 
acute exacerbation of asthma and 7.8% of total deaths were from acute asthma. There was 
generally poor adherence to the national guidelines with respect to the management of an 
acute asthma exacerbation. 
 
 
Aim and Objectives: 
 
This study aimed to assess and improve the quality of management of acute bronchospasm at 
Mitchell’s Plain CHC. Objectives included assessing the current management, comparing it 





The study methodology was that of an audit cycle. Eligible patients were identified from the 
casualty admissions register. A total of 351 patients’ records were reviewed and compared to 
criteria based on the national guidelines. The initial findings were presented to the casualty 
staff that critically reflected; planned and implemented change. Intervention strategies 
involved raising awareness about the asthma guidelines, the audit tool and the South African 





The baseline audit revealed that there was poor documentation of assessment of patients. 
Only 73% had a pulse rate documented, 70% had respiratory rate documented, 69% had 
blood pressure documented, 64% had temperature documented and 62% had pulse oximetry 
documented. Only 8% had peak expiratory flow rate (PEFR) before nebulisation and 9% had 
PEFR post nebulisation documented. Supplemental oxygen was documented in 6%. B2 
agonists was administered in 73% via saline nebulisation and 45% had Ipratropium Bromide 
nebulisation. Oral steroids were documented in 47% and intravenous steroids in 21%. The 
results of the re-audit showed improvement in the clinical assessment criteria of the patients 
triaged using the audit tool and SATS stationery with 3 of the 5 target standards being met. 
However, there was no improvement in the management of the acute bronchospasm as set out 





The quality of care of the management of acute bronchospasm at Mitchell’s Plain CHC was 
found to be below the standard set out in the guidelines. There was improvement in the 
assessment of patients following awareness of the guidelines, but not in the management of 
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acute bronchospasm. A number of factors could have contributed to this i.e. utilisation of 
junior doctors and locum doctors after-hours and general clinician inertia. These issues 


















































1. Study Title 
 
A Quality Improvement Cycle for Acute bronchospasm at Mitchell’s Plain Community 
Health Centre, Cape Town. 
 
 
2. Introduction and Literature review: 
 
Asthma is a chronic inflammatory condition of the airways, which is usually allergic in 
origin, and is characterized by hyper-responsive airways that constrict easily in response to a 
wide range of stimuli.1 Asthma affects over 300 million people worldwide and is the sixth 
highest cause of morbidity and mortality in South Africa,2 and is the second most important 
chronic disease after HIV/AIDS.3 It knows no prejudice, affecting people from all social, 
cultural and ethnic backgrounds unlike tuberculosis, which one would expect to encounter in 
less privileged societies, and coronary artery disease, which is a disease of affluence.4 
 
Asthma has become more common in both children and adults around the world in recent 
decades.1The increase in the prevalence of asthma has been associated with an increase in 
atopic sensitization and is paralleled by similar increases in other allergic disorders such as 
eczema and rhinitis.5 The prevalence of recent wheeze in adults is reported as 14.4% in males 
and 17.6% in females, with a self reported prevalence of 3.7% and 3.8% respectively.3 In the 
Western Cape the prevalence of asthma among children aged 3-14 years was 14.4%, slightly 
above the global average of 13.7%.3 With the projected increase in the proportion of the 
world's population that is urban from 45% to 59% in 2025, there is likely to be a marked 
increase in the number of asthmatics worldwide over the next two decades. It is estimated 
that there may be an additional 100 million persons with asthma by 2025.5 
 
District health services in the Western Cape Province serves 5 million people, of whom 80% 
are uninsured and depend on the public sector.3 Worldwide; asthmatics have restricted access 
to basic medications and medical care essential to treat their medical condition. 3Access to 
essential drugs for asthma, including inhaled steroids, is better in South Africa than in other 
sub-Saharan countries.3Increasing the economic wealth and improving the distribution of 
resources are important priorities in the move to improving health care globally.3 
 
The number of disability-adjusted life years (DALYs) lost worldwide has been estimated to 
be currently about 15 million per year.3Worldwide; asthma accounts for around 1% of all 
DALYs lost, which reflects the high prevalence and severity of asthma. The number of 
DALYs lost due to asthma is similar to that for diabetes, or cirrhosis of the liver, or 
schizophrenia.5 
 
 The burden of asthma worldwide is such, that it warrants recognition as a priority disorder in 
government health strategies.5 Emphasis should be placed on improving the care of 
disadvantaged groups with high morbidity, including certain racial groups and those who are 
poorly educated, live in large cities, or are poor.5Resources are also needed to address 
preventable factors, such as air pollution, that trigger exacerbations of asthma.5 It is estimated 
that asthma accounts for approximately 1 in every 250 deaths worldwide.5Many of these 
deaths are preventable, and are often the result of suboptimal long-term medical care and 





There are numerous barriers to reducing the burden of asthma, these can be generic, examples 
of which are poverty, poor education or infrastructure, environmental factors such as 
pollution, smoking, low public health priority due to the increased burden of tuberculosis and 
pneumonia in the face of HIV, or the inherent barriers in the organization of health care 
services in terms of; 
 Geography 
 Type of professional responding 
 Education and training systems 
 Public and private care 
 Tendency of care to be “acute” rather than “routine”5 
 
Asthma was the 25th leading cause of disability-adjusted life years (DALYs) lost worldwide 
in 2001.5 
 
The true prevalence of asthma is difficult to determine due to the lack of a single objective 
diagnostic test, different methods of classification of the condition, differing interpretation of 
symptoms in different countries, as well as the uncertain influence of increasing public and 
professional awareness of asthma. 
 
The prevalence of asthma is higher in Southern Africa than in many other regions in Africa.6 
Asthma is considerably more common in urban compared with rural areas. For example, in 
Zimbabwe the prevalence of exercise-induced asthma is 25 times higher in urban compared 
with rural communities, where asthma is rare.6There is a major preventable burden of asthma 
in the region due to under-recognition and under treatment, which are both in part related to 
limited access to health care. Asthma is a common cause of admission to hospital in the 
region, particularly in children. In the case of South Africa, asthma is the third most common 
cause of hospital admission in children, after pneumonia and gastroenteritis. In South Africa 
the number of admissions to hospital for asthma has increased markedly over the last few 
decades, with the greatest increase occurring among infants.5This suggests that the burden of 
severe asthma has increased markedly during this period.6 
 
 In Southern Africa, mining-related diseases such as pneumoconiosis remain the leading 
occupational respiratory diseases, but occupational asthma is becoming increasingly 
prevalent as non-mining industrialization expands.6 Occupational asthma now represents the 
second most frequently reported occupational respiratory disease. The Surveillance of Work-
related and Occupational Respiratory Diseases in South Africa (SORDSA) represents a good 
model for use in other countries to provide useful information on which to base prevention 
activities. Ethnic factors and socioeconomic status have only a modest effect on asthma 
prevalence but a large effect on asthma hospitalization and mortality rates. Improving the 
overall socioeconomic status of communities in the region represents a priority if the burden 
of disease, including that due to asthma, is to be reduced. The combination of changes in 
health services designed to improve access to and quality of asthma management and 
education in South Africa, and a national education program based on locally adapted 
guidelines, represents a good model for other countries in Africa to follow. The locally 
adapted guidelines, including those developed for children; provide a simple and practical 
approach applicable to local circumstances.6  
 
Despite progressive reductions over the last few decades, asthma mortality remains high 
within the region. For example, in South Africa among 5- to 34-year-olds the asthma 
mortality rate has decreased by 0.13 deaths per 100,000 per year over recent decades; 
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however at 1.5 it still represents a relatively high rate by international standards and is 
associated with the fifth-highest case fatality rate in the world.6 Asthma mortality rates are 
disproportionately higher in certain racial groups within the region. In South Africa the rates 
are highest amongst people of mixed race, followed by blacks and then whites. The majority 
of asthma deaths in the region occur outside hospitals. Poor availability of health care, poor 
transport and emergency services, and inadequate home management of acute asthma are 
recognized as important contributing factors.6    
 
Chronic obstructive pulmonary disease (COPD) is an important cause of death and disability 
in both developed and developing countries. It is becoming more common and accounts for 
significant and increasing utilization of health care resources with attendant increases in 
health care expenditure. Cigarette smoking remains the major cause of COPD, but in Africa 
and Asia domestic biomass fuel use and tuberculosis are important additional causes.7 COPD 
is a disease state resulting predominantly from smoking tobacco, and is characterized by 
airflow obstruction, which is generally progressive and is only partially reversible.7 
COPD is often diagnosed late because patients lack symptoms in the early stages of the 
disease despite the presence of moderate decreases in pulmonary function. The primary risk 
factor for COPD is cigarette smoking. However in South Africa, important contributory 
factors are tuberculosis, industrial and mining dust exposures, and domestic use of biomass 
fuels.7 As a result of these additional factors, the prevalence of COPD is higher in poorer 
communities (Table 1).7 It is not yet clear what impact HIV infection and its attendant 
pulmonary complications have on the pathogenesis and prevalence of COPD in South Africa. 
Estimates of the global all-age incidence of COPD are that it affects 9/1000 males and 
7.3/1000 females.7 It seldom presents clinically before the 5th decade, but incidence increases 
in successive decades and up to 50% of smokers over the age of 65 years are affected.7 
Incidence also varies widely between different regions and countries of the world, according 
to local cigarette smoking habits and domestic and socio-economic circumstances. It is more 
common in males than in females, but morbidity among women has increased sharply in 
many countries, in parallel with an increase in the number of women smokers. Morbidity and 
mortality increases with severity of disease, age and co-morbidity. The diagnosis of COPD 
should be considered in any patient with chronic dyspnoea and/or chronic cough (with or 
without sputum production), a smoking history of more than 10 pack years, and/or other risk 
factors for COPD (Table 1), particularly if there is no other apparent cause for these 
symptoms (e.g. cardiac failure).7 One pack-year equals 20 cigarettes per day, or 15g of pipe 
tobacco per day, for one year. In South Africa, more than one risk factor is commonly found.7 
 










An asthma exacerbation may be defined for practical purposes as a progressive (usually) or 
abrupt worsening of asthma symptoms with increase use of bronchodilators (rescue 
medication) with progressively decreasing response and/or a decrease in pulmonary function 
as measured by PEFR or spirometry.8 
Cigarette smoking 
Pulmonary tuberculosis 
Harmful exposures in mining and industry 
Smoking of marijuana 
Alpha-1 protease inhibitor deficiency (rare) 




The best strategy for the management of acute exacerbations of asthma is early recognition 
and intervention, before attacks become severe and potential life-threatening. Detailed 
investigations into the circumstances surrounding fatal asthma have frequently revealed 
failures on the part of both patients and clinicians to recognize the severity of the disease and 
to intensify treatment appropriately.9  
 
In the management of an acute exacerbation the basic principles are: 8-9 
 
1- Assess and classify the severity of the attack. 
 
- On presentation, a brief history and physical examination should be done immediately with 
simultaneous initiation of treatment. 
- The examination should assess for any other medical causes, such as pneumonia, 
pneumothorax, congestive cardiac failure etc. which often mimic the symptoms of an acute 
exacerbation of asthma. 
- Objective functional assessments such as baseline PEFR and arterial oxygen saturation 
measurement by pulse oximetry, before initiation of treatment, should be routine.8  
- PEFR measurement is preferred in emergency units and in primary health care as it is 
widely available, affordable, easy to use and safe. A baseline PEFR should be done before 
initiation of treatment, but may not always be possible in patients that are severely distressed. 
- Acute exacerbations are classified into mild, moderate or severe based on signs, symptoms 
and other relevant investigations. (Annexure A) 
 
2- Management of an acute exacerbation is done in a stepwise treatment approach, the 
mainstay of which is to; (Annexure B) 
 
- prevent worsening 
- improve symptoms by relieving airflow obstruction 
- treat hypoxia via administration of oxygen either by facemask or nasal cannula with the aim 
of maintaining saturation above 92%. Patients with COPD need supplemental oxygen to be 
administered cautiously, starting at 24% by nasal cannula, so as to prevent carbon dioxide 
narcosis and worsening of their symptoms. 
 
*B2 agonists; 
-short acting inhaled B2 agonists are generally used. B2 agonists act by stimulating the B2 
receptors in the airway.  
-they can be administered either by oxygen driven nebulization (preferred) or by metered 
dose inhalation via large volume spacer. 
-clinical improvement can be assessed against an increase in PEF of >60% of predicted or 
>60% of previous best. 
 
*Glucocorticoids; 
- Current guidelines recommend the use of glucocorticoids routinely for the treatment of 
acute asthma. 
- It can be administered in oral form, prednisone, at a dose of 0.5mg/kg or intravenously 
hydrocortisone, at a dose of 100-200mg, if patient is vomiting or unable to swallow. 
 
*Anticholinergics; 
-Inhaled ipratropium bromide is the only anticholinergic agent used in the treatment of acute 




*Magnesium sulphate (MgSO4); 
-It is thought that MgSO4 acts by inhibiting smooth muscle contraction, decreasing histamine 
release from mast cells and inhibits acetylcholine release hence resulting in bronchodilation. 
-It is used intravenously as a 1-2g infusion over 20 minutes.  
 
*Aminophylline; 
- Is no longer recommended in primary care setting due to its narrow therapeutic range and 
side effect profile, cardiac arrhythmias, convulsions, hypotension and coma. 
 
*Miscellaneous treatment; 
- Antibiotics are not routinely recommended and should only be given if there are signs of an 
infection 
 
3- Assessment of response to treatment; 
- Measurement of respiratory rate, pulse rate, PEFR and arterial oxygen saturation should be 
made at 15-30 minute intervals until a clear response to treatment is noted.8 
- Measurement of the change in PEFR in response to initial therapy is one of the best ways to 
assess response to treatment (PEFR at 30 minutes) is the most important predictor of outcome 
and indication for hospitalization. 
 
3.  Aims and objectives of the study 
 
Aim: 
The aim of this study was to assess the management of acute bronchospasm and to improve 
the clinical team’s awareness of and adherence to the national treatment guidelines at 
Mitchell’s Plain Community Health Centre (CHC), Cape Town, Western Cape.  
 
Objectives: 
1. To assess the current assessment and management of patients, presenting with acute 
bronchospasm. 
2.  To plan and implement changes to improve the assessment and management for such 
patients. 
3. To assess if these changes are associated with a measurable improvement in the assessment 
and management. 
4.  To make recommendations/ necessary changes to the Department of Health’s current audit 
tool for chronic diseases, with regards to acute bronchospasm, and interventions that may 
improve the quality of care at the CHC. 
      




The medical/clinical audit (Quality Improvement Cycle) is a well known tool used for 
assessing performance against established standards, and implementing appropriate change, 
as needed, to meet these standards. Continuous quality improvement is an important aspect of 
clinical governance. It involves both the critical application of research evidence and the 





The study design will follow the usual steps of the QIC: 
- Form a team to perform the audit that includes the key people involved in the topic at 
the local level. 
- Set target standards made up of evidence-based criteria and locally relevant 
performance levels. 
- Collect data to measure these target standards and compare actual performance to 
desired performance. 
- Plan and make changes to improve the quality of care. 
- Re-assess performance to determine if the quality of care has improved. 
   
Setting:   
 
Mitchell’s Plain CHC operates in the Mitchells Plain Health District of the Metro region 
under the Department of Health, Western Cape government. Mitchell’s Plain is a large area in 
Cape Town and according to the City of Cape Town 2011 Census, Mitchell’s Plain has a 
population of 310 485, 48.6% of which are male and 51.4%  female. The population is 
predominantly coloured, 91%, with an unemployment rate of 24.1%. 35% of those aged 20 
years and older have completed Grade 12 or higher, 76% of the labour force are aged 
between 15-64 years and are employed. 38% of households have a monthly income of 
R3200.00 or less, 95% of all households live in formal dwellings. 
 
Due to the influx of migrant workers, people seeking better prospects, a number of informal 
settlements have sprung up in and around the Mitchell’s Plain area; many of them drain to 
Mitchell’s Plain CHC after-hour services. 
 
Mitchell’s Plain CHC is staffed by a facility manager, one family physician, 5 medical 
officers, 2 intern doctors, 4 community service doctors, 4 clinical nurse practitioners, and an 
array of nursing staff. The CHC has a functional 24-hour casualty unit, 4-5 oxygen tanks are 
available, with two ECG machines in the facility, there is also a radiographer (who operates 
one X- ray machine) available during working hours, and after hours on Friday, as well as 
Saturday and Sunday. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Patients who present with acute bronchospasm are seen in ‘trauma’. There is currently an” 
Evidence-based local acute asthma guideline of 2007”, (Annexure B), available at Mitchell’s 
Plain CHC.  There is a physiotherapist as well as a social worker available on-site, however 
they are not involved with the management of asthma. 
Medications currently available for the treatment of acute bronchospasm include, B2- agonists 
(Salbutamol) and anticholinergic (Ipratropium bromide), by inhalation or by aerosol, steroids 
(oral prednisone or intravenous hydrocortisone), Magnesium sulphate (MgSO4) and 
antibiotics. 
 
Methods   
 
1. Create an Audit Team  
 
The clinical audit team at Mitchell’s Plain CHC consisted of the researcher and family 
physician in-charge as well as representatives from the pharmacy, nursing staff and 
reception. Permission was obtained from the facility manager of Mitchell’s Plain 
CHC to conduct the audit. The study was conducted between January 2012 and June 





2. Create a disease register 
 
The researcher created a disease register for patients with acute bronchospasm by 
identifying potential patients that were triaged according to the SATS with ‘tight 
chest’; cough; shortness of breath and wheeze. This information was obtained from 
the trauma register. The diagnosis was then confirmed by examining the medical 
records. A total of 351 patients were identified for the initial study period. In the 
initial audit 102 folders were identified following systematic randomisation, however 
26 folders had to be excluded i.e. 4 patients did not respond after their initial 
nebulisation, 13 were for other medical reasons (Annexure D) and 9 folders could not 
be located (Figure 1). In the re-audit; 249 folders were identified and there were 39 
exclusions, i.e.10 did not respond after the initial nebulisation, 16 were for other 





Figure 1: Folders excluded in the initial audit and the re-audit. 
 
3. Formulating target standards  
 
            Target standards set were based on the recommended criteria of the national guidelines 
(Table 2) with input from the audit team. Initially only the criteria were agreed upon and 

























Table 2: Criteria for assessing quality of care; 
            
 
Structural (Present on the 















units for both adults and 
paediatrics. 
 
Facemasks- various  
 




MDI’s with spacers 
 




% of patients with severity 
of asthma documented  
 




         -temperature 








        -facemask O2 
        -B2 agonist via spacer 
        -B2 agonist via neb 
       -Ipratropium Bromide 
neb 
    -corticosteroids- oral 
 -corticosteroids-IV 
 
% of patients with the 
following investigations 
done; 
-PEF before neb 
         -PEF after neb 
   -CXR if indicated 








Number of acute deaths 







4.   Data collection 
 
Identification of patients with acute bronchospasm was done retrospectively using the 
‘trauma” register, and a disease register was created with the criteria; tight chest, 
wheeze, shortness of breath and cough. Some of the patients listed did not have a 
diagnosis of acute bronchospasm once the file was examined and were excluded. (Figure 
1, Annexure D).  The data collection was done by the researcher using a standardised 





5.  Analyzing the data and comparing results to target standards 
 
An independent consultant was used for analysis of the data. Data from the audit was 
analysed using simple frequencies/percentages. 
 
6.   Planning Change  
The results of the analysis were presented to the audit team, as well as to health care 
providers from the Mitchells Plain CHC. A discussion with input from these key role-
players was then conducted as to what changes could realistically be implemented.   
 
7.  Implementation of change 
Once the team had been briefed, a plan of action was collectively decided upon. A 
period of approximately six months was given for the changes to be implemented.  
  
8.  Reflecting on results 
 Steps 4-6 were repeated, at the end of six months, and the data obtained at that point 
was a reflection of current practice after the initial intervention. Analysis assessed any 
significant changes in the criteria. Results were discussed with the health care providers 
and further changes planned, such as ensuring that a working saturation probe was 
always available in the triage room, all criteria were completed as per SATS 
requirements, PEF was done during routine chronic care and documented in patients 
clinic card and folders for quick and easy reference on presentation of an acute 
exacerbation, the audit tool to be added to the routine SATS form. A list of 
recommendations was compiled, including practical steps to address areas of concern. 
 
 Ethical considerations and reporting of results 
 
Ethical approval was obtained from the Health Research Ethics Committee of the University 
of Cape Town (Reference number, 431/2010). Permission was obtained from the Facility 
Manager and the Family Physician in-charge of Mitchell’s Plain Community Health Centre. 





The structural criteria were assessed by the researcher walking through the emergency unit 
and observing the items listed. All the items were available; however a paediatric BP cuff 
was the only exception.   
In the initial audit, a total of 76 patients were identified with acute bronchospasm, the mean 
age was 47 years and there were 39 (43.8%) females and 50 (56.2%) males. Table 3 shows 












Table 3: Data from baseline audit 
 
Process n % 
% of patients with severity of exacerbation documented in medical 
records 
 










#B2 agonist via spacer 
#B2 agonist via nebuliser 
#Ipratropium bromide 
#corticosteroids-oral 
#corticosteroids-IV     
 
% of patients with these investigations done;        
#PEF before nebulisation 
#PEF after nebulisation   
#CXR if indicated 
#ECG   
 


















































































The initial audit highlighted the following; 
 
The SATS sheet was not completed in accordance with the guidelines, an important 
parameter; pulse oximetry was only documented in 81% of folders assessed.  In the 
documented initial therapy for acute bronchospasm, oxygen forms the first part of treatment. 
From the data obtained, it is very difficult to comment on oxygen therapy specifically, as 
most patients received oxygen driven nebulisations and limitations with poor documentation 
of oxygen initiation also came into play. PEFR which is important to assess response to 
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treatment was only performed on 10% of folders assessed, even though this is not part of the 
SATS document, it forms part of the guidelines. Of the patients managed, 85% received a 
nebulised short-acting B2 agonist, and only 5% received Ipratropium Bromide.  It is unclear 
from the documentation if Ipratropium Bromide was used solely as an initial nebulisation, 
added to Salbutamol during initial nebulisation or as recommended by the guidelines. 
 
In terms of steroid therapy, prednisone and hydrocortisone were administered as initial 
steroid therapy. Prednisone was administered in 55% of cases. According to the 2013 SAMJ 
guidelines, oxygen, B2 agonists and steroids are usually administered concurrently to achieve 
the most rapid resolution of the attack and prevent relapse11. However, according to the 2008 
Standard treatment Guidelines, of bronchospasm after the initial nebulisation is not 
adequately reversed then oral prednisone is administered and thus prednisone might not have 
been required in all cases described above. Due to poor documentation, it is difficult to 
comment on why prednisone was not administered in most cases. Furthermore, 
hydrocortisone therapy was given in 25% of cases, very few cases demonstrated clear 
documentation for the indication of hydrocortisone and this leaves one to assume that 
hydrocortisone was administered inappropriately, but in truth one cannot be sure. 
 
Plan and implement changes to improve quality of care for acute bronchospasm; 
 
The initial audit findings were presented to the health care providers at Mitchell’s Plain 
Community Health Centre. At this meeting not all the role/key players were in attendance as; 
#trauma is ‘managed’ by community service doctors that rotate through the facility every 6 
months. At the time of the meeting post initial audit, these doctors were no longer part of the 
staff compliment. 
#not all the Clinical Nurse Practitioners that attended the meeting work in the trauma unit and 
those that do, do not see patients triaged ‘orange’ according to the SATS, beyond their scope 
of practise. 
 
#Mitchells Plain CHC is heavily reliant on ‘locum’ doctors that moonlight in the facility after 
hours. For many of them it is not their primary function and many of them work in other 
specialised fields, so they were not in attendance. 
 
The attending staff members that was inclusive of the trauma sister and the family physician, 
agreed to focus on improving the following key areas; 
*the clinical assessment of the patients- use of triage tool and audit tool 
*proper documentation of process 
*educate the locum doctors with regard to protocol  
 
Changes that were implemented: 
 at triage, each patient that presented with a tight chest, cough, wheezing or shortness 
of breath were triaged according to the SATS and emphasis was placed on pulse 
oximetry as this was important to the initial management.(Annexure B)  
 the audit form was attached to the SATS form to enable the health care provider to 
follow the step-wise management as set out in the guidelines handed to them and 
placed on the nebulisation room wall.  
 Prior to nebulisation each patient was expected to have PEFR done as well as after 
nebulisation to assess response to treatment. 
 All essential drugs, inhalants and other requirements essential to the management of 




The changes agreed to, were improvement of the triaging of the patients, by providing trauma 
nursing staff with triage training according to the SATS guidelines. The trauma manager was 
tasked with ensuring that all necessary equipment and medication was in stock and in good 
working order. The researcher was tasked with explaining the audit tool and guidelines to the 
health care providers. Performance levels for the process criteria related to the clinical 
assessment were decided upon by those in attendance and are shown in Table 4. 
Performance levels were not agreed upon for any other criteria. 
 
Implementation was done over a 6 month period and responsibility was taken on by the sister 
in charge of trauma; the researcher and the doctors working in the trauma unit. A printed 
guideline was set up in the asthma room and a typed sheet guiding the protocol, (Annexure 
D) was placed in each medical record of patients that presented with shortness of breath, 
wheeze, tight chest or cough. 
 
The post intervention audit consisted of 249 folders with 39 exclusions, (Annexure D). The 
total number of folders that were reviewed was n=210. The mean age was 46 years and there 
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#B2 agonists-via spacer 
                       -via nebulisation 
#Ipratropium bromide 
#corticosteroids-oral 
                             Intravenous 
 
% of patients with the following investigations; 
#PEF before nebulisation 
#PEF after nebulisation 
#CCXR if indicated 








































































































































































1. Key findings of the study 
 
The management of acute bronchospasm at Mitchell’s Plain CHC was below standard and 
had room for improvement. The clinical assessment of patients were incomplete despite the 
SATS tool being available and easily accessible for different age groups, the history taking 
and examination was inconsistent and severely lacking. Investigations essential to assessing 
response to treatment were not performed despite it being highlighted at the initial audit. 
 
Background history with regards to smoking and inhaler technique were not assessed and/or 
corrected if the need arose. Pharmacological management was inconsistent between the 
different health care providers despite a printed protocol being provided. 
 
As a result of the quality improvement cycle, a number of essential parameters were brought 
to the fore, the triage system had markedly improved, with patients being colour coded 
correctly and receiving attention timeously. Most of the target standards were met. Changes 
are still necessary in providing care, according to the ‘Guidelines for the management of 
acute asthma’, as the improvements proposed after the initial audit were not statistically 
significant and this can be brought about by re-addressing all the stakeholders. 
 
With the high turnover of trauma staff at Mitchell’s Plain CHC, the commitment to care of 
doctors, to improve care, was limited due to the perception that there is inadequate staff to 
service the population of Mitchell’s Plain. Also, ignorance and arrogance may have played a 
role, a number of locum doctors are registrars or super-specialists in their respective fields 
and moonlight at Mitchell’s Plain CHC and they are resistant to change, in terms of their 
training and knowledge. 
 
There is also the belief that patients should be held accountable for their own health and well 
being, because despite adequate health promotion and prevention  patients are not willing to 
be accountable for their own health and well being. 
 
The phenomenon of clinical inertia may also have contributed to the feedback received. 
Clinical inertia is defined as lack of treatment intensification in a patient, not at evidence 
based goals for care.14 It is a major factor that contributes to inadequate chronic disease 
management in patients with chronic diseases.14 
 
Despite the wide promulgation of clinical practise guidelines, it has had limited effect on 
changing physicians behaviour,9 and this can be attributed to the following barriers;  
 
#lack of awareness of appropriate guidelines-due to speciality backgrounds of some of the 
doctors 
#lack of familiarity with guidelines, due to lack of training 
#lack of agreement- provincial variation in management and pharmacotherapy 
#inertia of previous practise; the old adage; ’old habits die hard’ and resistance to change to 




There may also have been issues pertaining to the non-presence of the researcher. The family 
medicine rotation at its inception was not very structured, it was not always possible to be 
present at facility where research was carried out and very often the researcher had to depend 
on the good grace of fellow colleagues and the Family Physician to ensure that protocol and 
guidelines were adhered to. 
 
In terms of revising the audit tool for future use, I would recommend; 
 
# the inclusion of the PEFR predicted or personal best of the patient should be documented 
and easily accessible in the medical records for a quick reference and assessment of response 
to treatment. It should form part of the annual assessment in the chronic disease management. 
#Doctors may have recourse to their own clinical judgement when it comes to lifestyle 
modification as to what intervention is appropriate at the time of the  consult, an example 
would be , in a patient who does not smoke, it is inappropriate to advise them to stop 
smoking. The inclusion of lifestyle modification criteria as separate entities might result in 
seemingly sub-standard audit results in that field of assessment. 
 
Medical records did not indicate the severity of the acute bronchospasm and the intervention 
and response to the treatment, so whether Ipratropium bromide, oral or intravenous steroids 
were given in the correct sequence as indicated in the guideline, is uncertain. 
More accurate and detailed documentation is needed, not only for patient management but 
also for medico-legal purposes. 
 
The outcomes should remain unchanged.  
 
Continuing professional development programs in primary health care should focus on the 
acute management of bronchospasm and attempt to improve the competency of all health 
care providers. A separate study could be performed with health care providers, especially 
new community service doctors and locum doctors with other interests, to assess the 
adequacy of their knowledge with regard to guidelines and policy pertaining to the 
management of acute bronchospasm, this was however not a part of this quality improvement 
cycle. 
 
Family physicians and clinical managers should be made aware of the potential resistance to 
change experienced by staff when implementing quality improvement plans. This could be 
attributed to a survival mentality amongst the clinicians and inertia to take on new tasks. 
Further studies could explore this phenomenon and look at ways of creating an organisational 
culture more conducive to change and learning. Attention should also be directed to engaging 
staff in a process of critical reflection and to giving feedback in a way that encourages 
change. 
 
2. Comparison of findings to the literature: 
 
Clinical practise guidelines are” systematically developed statements to assist practitioners 
and patients decisions about appropriate health care for specific clinical circumstances.12 
Their successful implementation should improve quality of care by decreasing inappropriate 
variation and expediting the application of effective advances to everyday practise.12.  
The current guidelines for the management of acute asthma are easily tailored to a primary 
health care environment. It is comprehensive, easily adapted to different levels of care and 
user friendly. Doctors and relevant staff were presented with the proposed guidelines after the 
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initial audit. The initial audit may have yielded poor results due to the health care providers 
not having adequate exposure (locum doctors), or lack of relevant experience in utilizing the 
guidelines. 
 
There were no local published data regarding the quality of care of managing acute 
bronchospasm in primary health care. 
 
A study regarding the Quality of Asthma care: Western Cape Province, South Africa 3, 
assessed patients with chronic asthma within all six districts of the Western Cape, and 
concluded that, the availability of medication and prescription of inhaled steroids is 
reasonable, yet control is poor. Health workers do not adequately distinguish asthma from 
COPD, do not assess control by questions or PEF, do not adequately demonstrate or assess 
the inhaler technique, and have no systematic approach on resources for patient education3. 
 
Table 5: Results of asthma audit in the Western Cape Province.3 
 





Consulting rooms with (%):                                                            
  A functional PEFR meter 
 A reference chart for the PEFR 
 A published asthma guideline 
 A spacer for demonstration and education 
 Placebo inhalers for demonstration and education 
 Printed patient education material 
 
Facilities with (%) 
 A member of staff with ongoing responsibility for asthma 
 Provision for group health education on asthma 
 Patient education materials in all languages 
 A height measure 
 A spacer in the emergency room 
 A nebuliser in the emergency room 
 Oxygen in the emergency room 
 A PEF meter in the emergency room 
Medication in stock on day of audit 
Medication in stock over previous month 
 
Process 
Patients with a consistent diagnosis of asthma (%) 
Routine visits with an assessment of asthma control (%) 
Patients with written self-management plan (%) 
Routine visits where the PEFR was recorded (%) 
Patients with an assessment of inhaler/spacer technique (%) 



































































Patients who are totally/well controlled (%) 
Patients who can explain the difference between reliever and 
controller (%) 
Proportion of all visits for asthma emergencies/exacerbations 















A study conducted to assess the “Perceptions, impact and management of asthma in South 
Africa: a patient questionnaire study conducted in South Africa; concluded that, the need for 
asthma control has been under-recognised and poorly attended in South Africa.4 The Asthma 
Education Programme of South Africa now has a clear mandate to upgrade education of both 
doctors and patients.4 The mere publication of asthma guidelines is now recognised as being 
insufficient to address this problem.4 
A similar conclusion can be reached in this study, despite provision of the asthma guideline 
and the availability of all drugs and equipment, the health care provider’s knowledge of the 
acute management of bronchospasm was not assessed. 
 
In a summary, comparison of 5 current guidelines for asthma management, it was concluded 
that though asthma guidelines may not be perfect, they are the best vehicle to assist primary 
care physicians to provide the best possible asthma care.15 
 
In the article, Managing Asthma in Primary Care: Putting New Guideline Recommendations 
into Context16, evidence continues to show that, for a substantial number of patients, asthma 
control is inadequate.16 The article goes on to explain that, “Physicians have a tendency to 
underestimate the prevalence of asthma symptoms and to overestimate the degree to which 
their patients’ asthma is controlled.16 Physicians may also have an inadequate understanding 
of disease aetiology or may not communicate well with patients, and these problems make it 
difficult to establish a pharmaco-therapeutic regimen that the patient is willing to follow.16 
 
The use of guideline based treatment strategies has been shown to favourably affect asthma 
outcomes, but there has also been increasing recognition that previous guidelines were not 
adequately followed and did not lead to acceptable levels of asthma control.16  
 
3. Limitations of the study design / methods 
 
Limitations of the study related to: 
 
A) Trauma register 
 
 There were numerous entries in the trauma register with patient details but no 
diagnosis documented, there many cases of bronchospasm may have been missed. 
 Illegible handwriting posed a major problem. An example is the inability to 
distinguish between words such as ‘asthma’ and ‘assault.” 
 Vague diagnosis was also a problem in some instances. An example would be an 
entry of ‘SOB’(shortness of breath). This was only included if the subsequent 
management illustrated a ‘Neb’ (nebulisation). In cases where no management was 




The above factors could have influenced the number of patients that were illegible for the 
study. 
 
B) Folders reviewed 
 
 There were a number of folders that were requested but not obtained, 9 in the initial 
audit group and 11 in the post-audit group, which could have affected the number of 
cases that were entered into the study. 
 There were cases that were initially diagnosed as ‘tight chest, cough, wheeze or SOB’ 
but were found on examination not to have acute bronchospasm.  
 Temporary folders that were issued, either due to original folders not being found or 
computers off-line, at the time of presentation were not available when requested. 
 Scrutiny of some of the folders demonstrated that admission notes were ‘missing’ and 
therefore could not be used in the study. 
 Failure of correct and adequate documentation by doctors was a significant limitation. 
 
The researcher was not on-site during the re-audit, due to the nature of the family medicine 
rotation. This could have influenced staff, in the use of the audit tool and in following the 
guidelines issued. 
Mitchell’s Plain CHC is reliant on community service doctors that work on a six monthly 
rotation and locum doctors that moonlight at Mitchell’s Plain after hours, due to these factors 
the same staff were not present at the presentation of the initial audit findings. This, together 
with the absence of the researcher could influence the final results. 
 
Although Mitchell’s Plain CHC is fairly typical of health centres in the Western Cape there is 
variation in staffing levels, organisation of care and competency of staff between the various 
health care centres. The quality of care therefore may not be exactly generalizable to all other 
health care centres. However the quality of care is unlikely to differ vastly and one can 




The current quality of care of acute bronchospasm at Mitchell’s Plain CHC is below standard 
and there is room for improvement. Due to the large staff turnover there were inconsistencies 
in the management and guidelines were not always followed, this could be due to the way in 
which the feedback was disseminated. Nevertheless critical reflection led to improvement in 
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